Vanda Pharmaceuticals, Inc. (VNDA)
7.50
-0.07
(-0.92%)
USD |
NASDAQ |
Feb 09, 13:55
Vanda Pharmaceuticals EPS Diluted (Quarterly) : -0.3822 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.390 |
| AbbVie, Inc. | 1.024 |
| Axsome Therapeutics, Inc. | -0.9442 |
| AnaptysBio, Inc. | 0.5208 |
| SELLAS Life Sciences Group, Inc. | -0.0626 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.59M |
| Revenue (Quarterly) | 56.26M |
| Total Expenses (Quarterly) | 78.84M |
| Enterprise Value | 164.52M |
| Gross Profit Margin (Quarterly) | 91.64% |
| Profit Margin (Quarterly) | -40.15% |
| Earnings Yield | -19.09% |
| Normalized Earnings Yield | -19.09 |